§ 13F · FUND PROFILE
NEXTBio Capital Management LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 23Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$170.5T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | TERN | TERNS PHARMACEUTICALS INC | 551K | $22.3T | 13.1% | NEW |
| 2 | PTGX | PROTAGONIST THERAPEUTICS INC | 230K | $20.1T | 11.8% | NEW |
| 3 | VOR | VOR BIOPHARMA INC | 1000K | $13.1T | 7.7% | NEW |
| 4 | ZBIO | ZENAS BIOPHARMA INC | 322K | $11.7T | 6.9% | NEW |
| 5 | STTK | SHATTUCK LABS INC | 3.15M | $11.5T | 6.7% | NEW |
| 6 | VSTM | VERASTEM INC | 1.31M | $10.1T | 5.9% | NEW |
| 7 | PVLA | PALVELLA THERAPEUTICS INC NE | 83K | $8.7T | 5.1% | NEW |
| 8 | XENE | XENON PHARMACEUTICALS INC | 184K | $8.2T | 4.8% | NEW |
| 9 | RYTM | RHYTHM PHARMACEUTICALS INC | 68K | $7.2T | 4.2% | NEW |
| 10 | GPCR | STRUCTURE THERAPEUTICS INC | 94K | $6.6T | 3.9% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE NEXTBIO SIGNAL
AC read
NEXTBio Capital Management LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed